RVL Pharmaceuticals plc
RVLPDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739426
RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding RVL Pharmaceuticals plc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 46 | 36 | −10 |
| Shares | 24.0M | 25.1M | +1.08M (+4.5%) |
| Value | $50.5M | $28.0M | −$22.5M (−44.5%) |
New holders (1)
Institutions that held RVL Pharmaceuticals plc at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bridgeway Capital Management, LLC | 31,500 | $35.3K | 0.00% |
Sold out (11)
Institutions that held RVL Pharmaceuticals plc at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| UBS Oconnor LLC | 276,428 | $580.0K |
| IPG Investment Advisors LLC | 17,500 | $36.8K |
| Two Sigma Securities, LLC | 16,298 | $34.0K |
| Tower Research Capital LLC (TRC) | 15,483 | $32.0K |
| Marshall Wace, LLP | 11,300 | $24.0K |
| Ergoteles LLC | 10,927 | $23.0K |
| Citigroup Inc | 8,356 | $18.0K |
| Huntington National Bank | 1,650 | $3.00K |
| IFP Advisors, Inc | 306 | $2.00K |
| Royal Bank of Canada | 294 | $1.00K |
| Tilia Fiduciary Partners, Inc. | 435 | $1.00K |